About CVR Medical Corp.

This author has not yet filled in any details.
So far CVR Medical Corp. has created 77 blog entries.
7 05, 2018

Canon Showcasing Carotid Stenotic Scan (CSS) At NPE The World’s Leading Plastic Tradeshow

By | May 7th, 2018|Press Release|0 Comments

VANCOUVER, BC / May 7, 2018 / CVR Medical Corp.  (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) ("CVR Medical”) is pleased to announce that Canon Virginia, Inc. (CVI) will be showcasing our Carotid Stenotic Scan (CSS) at NPE 2018: The Plastics Show, the world’s leading plastic tradeshow. Canon Virginia, Inc. (CVI), a wholly owned subsidiary of Canon [...]

3 05, 2018

Tom J. Harris Former CFO At Time Warner Cable And Associated Press Appointed Chief Financial Officer Of CVR Medical

By | May 3rd, 2018|Press Release|0 Comments

VANCOUVER, BC / May 1, 2018 / CVR Medical Corp.  (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) ("CVR Medical”) has appointed Mr. Tom J. Harris to the position of Chief Financial Officer effective May 1, 2018. As CVR transitions to a sales and marketing focused company, Mr. Erwin Wong retires from his position as CFO. Tom J. [...]

1 05, 2018

CVR Medical Bolsters Board Appoints Wayne Hellman Vice-Chairman

By | May 1st, 2018|Press Release|0 Comments

Global Thought Leader and Entrepreneur Adds Tremendous Expertise in New Product Launches, International Expansion and Manufacturing VANCOUVER, BC / May 1, 2018 / CVR Medical Corp.  (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) ("CVR Medical”) is pleased to announce the addition of Mr. Wayne Hellman to its Board of Directors and appointment as Vice-Chairman.  Mr. Hellman will [...]

16 04, 2018

CVR Medical Announces Proposed Financing

By | April 16th, 2018|Press Release|0 Comments

VANCOUVER, BC / April 16, 2018 / CVR Medical Corp.   CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) announces that it intends to complete a private placement financing for gross proceeds of up to $1,000,000 (the "Financing"), which is expected to consist of units, with each unit comprised of one common share and [...]

10 04, 2018

CVR Medical Announces Closing of Temporary Warrant Exercise Price Amendment

By | April 10th, 2018|Press Release|0 Comments

VANCOUVER, BC / April 10, 2018 / CVR Medical Corp.   CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) ("CVR Medical") today announced that the temporary warrant exercise price amendment expired at the close of business on April 6, 2018 (the "Amendment"). An aggregate of 2,518,600 warrants originally issued in the February and April, 2017 private [...]

19 03, 2018

CORRECTION: CVR Medical Announces Temporary Warrant Exercise Price Amendment – Company To Host Conference Call

By | March 19th, 2018|Press Release|0 Comments

VANCOUVER, BC / March 19, 2018 / CVR Medical Corp. The press release that follows is re-issued due to a typographical error in the access code of the original release (issued on March 16, 2018 at 5:30 a.m. PST) whereby access code to the conference call scheduled for March 19, 2018 at 1:00 p.m. EST [...]

16 03, 2018

CVR Medical Announces Temporary Warrant Exercise Price Amendment – Company To Host Conference Call

By | March 16th, 2018|Press Release|0 Comments

VANCOUVER, BC / March 16, 2018 / CVR Medical Corp. CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) ("CVR Medical") today announced that it will temporarily reduce the exercise price of its outstanding 2017 warrants originally issued in February and April 2017 (the "2017 Warrants") from CAD $0.70 (the "Original Exercise Price") to CAD $0.40 [...]

7 03, 2018

Second Trial Data Report: Clinical Substantiation for CVR Medical

By | March 7th, 2018|Press Release|0 Comments

VANCOUVER, BC / March 7, 2018 / CVR Medical Corp. (TSX.V: CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical”) advisory staff member Dr. Phillip J. Bendick, PhD, has completed his second clinical report summarizing additional data collected from tertiary clinical trials for the Carotid Stenotic Scan (CSS) device. His report confirms the evaluation stated in the [...]

27 02, 2018

CVR Medical Expands Clinical Footprint

By | February 27th, 2018|Press Release|0 Comments

VANCOUVER, BC / February 27, 2018 / CVR Medical Corp. (TSX.V: CVM.V) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical”) announces Internal Review Board (IRB) approval by The Cleveland Clinic, sanctioning CVR to conduct clinical trials using the Carotid Stenotic Scan (CSS) device. The trial will be overseen by Primary Investigator Dr. Heather Gornik, Medical Director of [...]

20 02, 2018

Critical Milestone: CVR Medical to Launch Pivotal Trials

By | February 20th, 2018|Press Release|0 Comments

VANCOUVER, BC / February 20, 2018 / CVR Medical Corp. (TSX.V: CVM.V) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical”) announces the launch of pivotal clinical trials beginning Monday March 5, 2018 for the Carotid Stenotic Scan (CSS) device. This anticipated milestone represents the final phase of clinical substantiation which CVR will use to support the upcoming [...]